- Aeglea BioTherapeutics (NASDAQ:AGLE): FY GAAP EPS of -$1.52 beats by $0.04.
- Cash, cash equivalents, marketable securities and restricted cash of $148.1M
- Press Release
Aeglea BioTherapeutics EPS beats by $0.04
Recommended For You
More Trending News
About SYRE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SYRE | - | - |
Spyre Therapeutics, Inc. |